Pyrexia, commonly known as fever, is a frequently encountered symptom in clinical practice. Despite its ubiquity, its management often poses a challenge due to the myriad of underlying causes and clinical presentations. This guide aims to provide a comprehensive overview of the management of pyrexia.
Pyrexia is typically a response to an infection, but can also be a symptom of autoimmune diseases, malignancies, or drug reactions. It is a complex physiological process involving the hypothalamus, prostaglandins, and pyrogens. Understanding the etiology and pathophysiology is pivotal for targeted treatment.
The clinical assessment of a febrile patient should be thorough and systematic. History taking should focus on potential sources of infection, recent travel, medication use, and associated symptoms. Physical examination should be comprehensive, with attention to signs of specific syndromes. Diagnostic tests should be guided by clinical suspicion.
Management of pyrexia involves treating the underlying cause and symptomatic relief. Antipyretics, such as paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs), are commonly used for symptomatic relief. Antibiotics or antivirals may be required if an infection is identified. In cases of non-infectious causes, management should be tailored to the specific condition.
Regular monitoring of the patient's temperature and response to treatment is crucial. Any changes in the clinical picture should prompt reassessment and potential modification of the management plan. Follow-up is essential to ensure resolution of the fever and to manage any long-term sequelae.
Pyrexia is a common yet complex clinical symptom. Its effective management requires a comprehensive understanding of its etiology and pathophysiology, along with a systematic approach to clinical assessment and management. Regular monitoring and follow-up are also crucial to ensure optimal patient outcomes. This guide provides a practical approach to managing pyrexia in clinical practice.
1.
Is Laughter Good for Blood Glucose Control?
2.
NIH research cuts leave cancer patient facing hard choice
3.
Scientists Employ Technology to Identify Plagiarism and Forgeries in Published Studies.
4.
Ruxolitinib Reduces Acute GVHD in Transplant Patients
5.
Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals
1.
The Revolutionary Treatment of Hodgkin's Lymphoma: A New Hope for the Future
2.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
3.
Aging of Bone-Marrow Immune Niches: Mechanisms, Clinical Impact, and Therapeutic Horizons
4.
Biomarkers of Marrow Regenerative Capacity Following Repeated Hematopoietic Stress
5.
Consensus Recommendations for Healthy Hematologic Aging
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
2.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
3.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
5.
Updates on the First Line Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation